G. Robinet

14.5k citations
110 papers · 3.2k · 1 hit paper · h-index 24

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
    • Brain Metastases and Treatment
  • Oncology top 1%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies

Papers in

    • Lung Cancer Treatments and Mutations 50
    • Brain Metastases and Treatment 11
    • Lung Cancer Diagnosis and Treatment 10
    • Lung Cancer Research Studies 34
    • Cancer Immunotherapy and Biomarkers 18
    • Cancer Treatment and Pharmacology 12
    • Colorectal Cancer Treatments and Studies 10

G. Robinet

105 papers receiving 3.0k citations

G. Robinet's Hit Papers

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer 2013 · 379 citations
3790+4+8Years since publication100200300

Peers

G. Robinet
Comparison fields: 5 of 88
  • Pulmonary and Respiratory Medicine 1.9k
  • Oncology 1.6k
  • Hepatology 198
  • Cancer Research 229
  • Genetics 133
Replace Russell F. DeVore with:
Russell F. DeVore United States
Ichiro Takata Japan
Panos Fidias United States
Hirohito Tada Japan
Davey B. Daniel United States
Joo Hang Kim South Korea
Francisco Robert United States
Jerome C. Landry United States
Willemijn S.M.E. Theelen Netherlands
Stephen Shibata United States
G. Robinet relative to Russell F. DeVore United States Russell F. DeVore's profile →
Citations per field
00.5×3.1×
Russell F. DeVore · 1×
Citations per year

Countries citing papers authored by G. Robinet

Since Specialization
Citations

This map shows the geographic impact of G. Robinet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Robinet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Robinet more than expected).

Fields of papers citing papers by G. Robinet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Robinet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Robinet. The network helps show where G. Robinet may publish in the future.

Co-authors

The 25 scholars most cited alongside G. Robinet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G. Robinet Line = papers co-authored together G. Robinet links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2005434
2
Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
Hit paper breakdown →
2013379
3 2007216
4 2001213
5 2000186
6 2011185
7 2011154
8 2014137
9 2001136
10 201874
11 201762
12 202158
13 201951
14 202042
15 200640
16 200132
17 200232
18 200429
19 201327
20 201027

About G. Robinet

G. Robinet is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 110 papers that have together received 3.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (50 papers), Lung Cancer Research Studies (34 papers), Cancer Immunotherapy and Biomarkers (18 papers), Cancer Treatment and Pharmacology (12 papers), Brain Metastases and Treatment (11 papers), Colorectal Cancer Treatments and Studies (10 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Cancer therapeutics and mechanisms (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.9k citations), Oncology (1.6k citations), Hepatology (198 citations), Cancer Research (229 citations) and Genetics (133 citations). G. Robinet has collaborated with scholars based in France, United States and Italy. Frequent co-authors include M. Pérol, A. Vergnenègre, P. Thomas, P. Fournel, Fabrice Barlési, H. Léna, H. Léna, F. Mornex, D. Paillotin and J. Le Treut. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology and Targeted Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact